Scarica l'app Stockscreener
15.69
1.62%
0.25
Pre-mercato:
15.60
-0.09
-0.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M - Investing.com
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst - Benzinga
Adaptive Biotechnologies inks two agreements with Pfizer in immunology - Investing.com India
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research - Reuters
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M By Investing.com - Investing.com South Africa
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - Yahoo Finance
Adaptive (NASDAQ: ADPT) signs RA TCR, data licensing pacts with Pfizer (NYSE: PFE) - Stock Titan
How Investors Are Reacting To Adaptive Biotechnologies (ADPT) clonoSEQ Data Shaping MRD-Guided Cancer Care - Yahoo Finance
Insider Sell: Robert Hershberg Sells 22,968 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies (ADPT) falls 24.5% as execs dispose millions of stake - MSN
Take off with Adaptive Biotechnologies Corp (ADPT): Get ready for trading - setenews.com
Adaptive Biotechnologies to Discuss clonoSEQ Technology and Minimal Residual Disease at Jefferies Fireside Chat - Quiver Quantitative
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease - Yahoo Finance
Adaptive Biotechnologies chief commercial officer sells $212k in stock - Investing.com
Adaptive Biotechnologies (ADPT) Falls 24.5% as Execs Dispose Millions of Stake - Insider Monkey
Adaptive Biotechnologies CEO Chad M Robins Sells $3M in Company Shares - StocksToTrade
Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at ASH Meeting - GuruFocus
Adaptive Biotechnologies Stock Declines After Insider Sale - timothysykes.com
December Disappointments: 10 Big Names Troubled Early - Insider Monkey
Seattle InnoLayoffs at Adaptive I Rover's marketing efforts - The Business Journals
Adaptive Biotechnologies’ Stock Faces Turmoil Amid Insider Selling - StocksToTrade
Adaptive Biotechnologies Corporation Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting - marketscreener.com
Adaptive Biotechnologies Highlights Expanded Clinical Use of clonoSEQ® Test at 67th ASH Annual Meeting - Quiver Quantitative
Adaptive Biotechnologies (Nasdaq: ADPT) shows clonoSEQ MRD guiding blood cancer care at ASH 2025 - Stock Titan
Insider Sell: Harlan Robins Sells 37,212 Shares of Adaptive Biot - GuruFocus
Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock - Investing.com
Adaptive Biotechnologies Exec Sells Over $670K in Company Stock - TradingView
Officer Robins Sells 37,212 ($672.5K) Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Adaptive Biotechnologies (ADPT) Is Down 11.2% After Earnings Beat And CFO Share SaleHas The Bull Case Changed? - simplywall.st
Will Adaptive Biotechnologies Corporation stock beat EPS estimatesDollar Strength & AI Enhanced Trading Alerts - Newser
Officer Robins Files To Sell 10,000 Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Will Adaptive Biotechnologies Corporation (1HM) stock draw ESG focused funds2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Will Adaptive Biotechnologies Corporation (1HM) stock sustain uptrend momentum2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback - Yahoo Finance
Ready to Jump After Recent Trade: Adaptive Biotechnologies Corp (ADPT) - setenews.com
Adaptive biotechnologies CFO Piskel sells $3.17 million in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $2,367,462.12 in Stock - MarketBeat
ADPT FinancialsIncome Statement - Quiver Quantitative
Adaptive biotechnologies CFO Piskel sells $3.17 million in stock - Investing.com
Adaptive Biotechnologies CFO Kyle Piskel Sells Over 162K Shares - TradingView
CFO Piskel Sells 162,820 ($3.2M) Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Adaptive Biotechnologies (ADPT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ameritas Investment Partners Inc. Raises Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - Defense World
Chad Robins Sells 160,734 Shares of Adaptive Biotechnologies Cor - GuruFocus
Adaptive Biotechnologies CEO Robins sells $3.07 million in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies CEO Robins sells $3.07 million in stock - Investing.com
Adaptive Biotechnologies CEO Sells Shares Worth Over $3 Million - TradingView
Chmn Robins Sells 160,734 ($3.1M) Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Chmn Robins Files To Sell 124,998 Of Adaptive Biotechnologies Corp [ADPT] - TradingView
CFO Piskel Files To Sell 162,820 Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Geode Capital Management LLC Has $37.46 Million Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Street Watch: Why Adaptive Biotechnologies Corporation stock remains undervaluedGlobal Markets & Weekly High Return Opportunities - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Adaptive Biotechnologies Corp - Setenews
Sharon Benzeno Sells 308,477 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Adaptive Biotechnologies’ Benzeno sells $10.1m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies’ Benzeno sells $10.1m in shares - Investing.com
Adaptive Biotechnologies CCO reports major option exercises, sales - Stock Titan
Officer Benzeno Sells 606,402 ($10.1M) Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test at Hemat - GuruFocus
Adaptive Biotechnologies' clonoSEQ® Test Featured in 89 Abstracts at ASH Annual Meeting 2025 - Quiver Quantitative
Adaptive Biotechnologies (ADPT) Highlights clonoSEQ in 89 ASH Abstracts, 36 Orals - Stock Titan
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):